BioCentury
ARTICLE | Financial News

EndoCeutics amends IPO

May 12, 2007 12:21 AM UTC

EndoCeutics (Quebec City, Quebec) lowered the proposed price range of its IPO and now hopes to sell 5.8 million shares at $7-$9 instead of $11-$13 in an offering on NASDAQ. An $8 price would raise $46...